Dutch Biotech fighting ALS and other neuro-degenerative diseases gets European backing

الملخص

The European Investment Bank (EIB) has signed a €30 million convertible loan agreement with Amsterdam-based VectorY Therapeutics, a clinical-stage biotechnology company developing a novel treatment for…